SpeeDx products
Respiratory Infections
PlexPCR - COVID-19 Causative Coronavirus
Detect COVID-19 causative coronavirus, SARS-CoV-2; Multiplex RT-qPCR test with dual targets (RdRp/ORF1ab) and RNA-based internal control in a single-well. Scalable solution supporting surge capacity.
Sexually Transmitted Infections
ResistancePlus - Gonorrhoea and Ciprofloxacin Susceptibility
Single well qPCR test for detection of Neisseria gonorrhoeae and markers linked to ciprofloxacin susceptibility validated on a range of specimens and collection vessels. Antibiotic resistance in gonorrhoea infections is a global concern. There are limited effective treatment options and novel antibiotics are not readily available. Smarter and more directed use of antibiotics can be achieved through Resistance Guided Therapy. Global surveillance data indicate 50-70% of gonorrhoea infections remain susceptible to ciprofloxacin. Guidelines for gonorrhoea management call to preserve ceftriaxone and recommend use of ciprofloxacin when susceptibility information is available. Azithromycin resistance is rising, compromising dual-therapy options.
ResistancePlus - Mgen and Macrolide Resistance
Single well qPCR test for detection of Mycoplasma genitalium (Mgen) and macrolide resistance markers validated on a range of specimens and collection vessels. Resistance to the macrolide treatment (Azithromycin) is of growing concern when managing M. genitalium (Mgen) infections. Guidelines around the world now call for the practice of Resistance Guided Therapy to guide appropriate treatment decisions, reduce potential for spreading infection among vulnerable populations, and support antibiotic stewardship.Resistance Guided Therapy is clinically demonstrated to improve patient cure rate and overall patient management. Detection of macrolide resistance can reduce time to cure, preventing ongoing transmission.